When was Venturemed Group founded?

Venturemed Group was founded in 2012 and raised its 1st funding round 5 years after it was founded.

Where is Venturemed Group located?

Venturemed Group is headquartered in Toledo, United States.

How many employees does Venturemed Group have?

As of Jul 16, 2025, the latest employee count at Venturemed Group is 11 - 50.

Is Venturemed Group a funded company?

Venturemed Group is a funded company, having raised a total of $72.2M across 5 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Aug 15, 2017.

When was the latest funding round of Venturemed Group?

Venturemed Group's latest funding was a $***** Series C round on Oct 17, 2025, with participation from 2 investors. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.1B in funding in 2026 to date.

Where does Venturemed Group rank among its competitors?

Venturemed Group ranks 4th amongst 40 active competitors, of which 14 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Cagent Vascular, which secured $41M in May, 2026.

Who are the top competitors of Venturemed Group?

Venturemed Group's top competitors include Okami Medical, LeMaitre Vascular and Cagent Vascular. Among them, Cagent Vascular secured the most recent funding round in May, 2026.

Venturemed Group - 2026 Company Profile, Team, Funding & Competitors

Venturemed Group is a series C company based in Toledo (United States), founded in 2012 by John Pigott. It operates as a Developer of endovascular devices for the treatment of PAD and stenoses of AV fistulas and grafts. Venturemed Group has raised $72.2M in funding from investors like Endeavour Vision, S3 Ventures and RiverVest Venture Partners. The company has 40 active competitors, including 14 funded and 11 that have exited. Its top competitors include companies like Okami Medical, LeMaitre Vascular and Cagent Vascular.

Company Details

Developer of endovascular devices for the treatment of PAD and stenoses of AV fistulas and grafts. The company has developed, FLEX Scoring Catheter, a single-use, disposable device designed to facilitate the dilation of stenoses. It is indicated for use with PTA catheters to facilitate dilation of stenoses in the femoral and popliteal arteries and treatment of obstructive lesions.

Website: venturemedgroup.com
Email ID: *****@venturemedgroup.com
Phone Number: +1 **********

Key Metrics

Founded Year

2012

Location

Toledo, United States

Stage

Series C

Total Funding

$72.2M in 5 rounds

Latest Funding Round

Series C, Oct 17, 2025, $*****

Investors

Endeavour Vision & 4 more

Ranked

4^th among 40 active competitors

Employee Count

11 - 50 as on Jul 16, 2025

Similar Companies

Okami Medical & 48 more

View Venturemed Group's full profile

Venturemed Group has raised a total funding of $72.2M over 5 rounds. Its first funding round was on Aug 15, 2017. Its latest funding round was a Series C round on Oct 17, 2025 for $*****. 2 investors participated in its latest round. Venturemed Group has 5 institutional investors.

Here is the list of recent funding rounds of Venturemed Group:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 17, 2025	7038215	Series C	6675672	4327470	3456988	8539830
Oct 31, 2024	1573497	Series B	9402856	4513423	2952135	3048539
Nov 23, 2021	3731252	Series B	7660193	1035254	Endeavour Vision & 1 more	4324269

Access funding benchmarks and valuations. Sign up today!

View details of Venturemed Group's funding rounds and investors

The founders of Venturemed Group is John Pigott. Denis Harrington is the CEO of Venturemed Group.

Here are the details of Venturemed Group's key team members:

John Pigott: Founder of Venturemed Group.
Contact Info: 1 email address

View details of Venturemed Group's Founder profiles and Board Members

Venturemed Group's employee count trend

Venturemed Group has 11 - 50 employees as of Jul 25. Here is Venturemed Group's employee count trend over the years:

Employee count trend for Venturemed Group

Uncover Venturemed Group's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Venturemed Group include Okami Medical, LeMaitre Vascular and Cagent Vascular. Here is the list of Top 10 competitors of Venturemed Group, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Okami Medical 2011, Aliso Viejo (United States), Series F	Developer of innovative, versatile, and intuitive medical devices for peripheral vessels treatment	$107M	Gilde Healthcare, Vensana Capital & 6 others	62/100
2nd	LeMaitre Vascular 1983, Burlington (United States), Public	Vascular surgery solutions innovator, improving patient lives with thoughtfully designed devices	$5.83M	Royce Investment Partners, Conestoga Capital Advisors ... & 1 others	58/100
3rd	Cagent Vascular 2014, Wayne (United States), Series D	Developer of a device for removal of vascular blockages	$110M	USVP, Sectoral & 9 others	58/100
4th	Venturemed Group 2012, Toledo (United States), Series C	Developer of endovascular devices for the treatment of PAD and stenoses of AV fistulas and grafts	$72.2M	RiverVest Venture Partners, Endeavour Vision ... & 3 others	55/100
5th	Pathway Medical Technologies 1998, Kirkland (United States), Acquired	Provider of smart devices to clear peripheral arterial blockages	$102M	LVP, HLM Venture Partners & 8 others	52/100
6th	Avinger 2007, Redwood City (United States), Public	Provider of image-guided catheter-based products for peripheral artery disease	$171M	CRG, Emergent Medical Partners & 6 others	51/100
7th	AtheroMed 2006, Menlo Park (United States), Acquired	Peripheral atherectomy catheter for peripheral arterial disease	$24.7M	Canaan, Kaiser Permanente Ventures & 2 others	42/100
8th	Truvic 2014, Campbell (United States), Acquired	Developer of smart devices for peripheral vascular disease management	$5.89M	Ascension Ventures, AMED Ventures & 1 others	40/100
9th	Eximo Medical 2012, Rehovot (Israel), Acquired	Hybrid catheters for vascular procedures	$1.6M	Accelmed Ventures, Accelmed & 6 others	40/100
10th	Idev Technologies 2000, Houston (United States), Acquired	Self expanding stent system	$58.9M	Piper Jaffray, RiverVest Venture Partners ... & 3 others	39/100